tiprankstipranks
OncoZenge AB (DE:8LY)
FRANKFURT:8LY
Germany Market

OncoZenge AB (8LY) Cash flow

0 Followers

OncoZenge AB Cash Flow

DE:8LY's free cash flow for Q2 2022 was kr-6.32M. For the 2022 fiscal year, DE:8LY's free cash flow was decreased by kr-10.12M and operating cash flow was kr-6.32M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 21Dec 20
Operating Cash Flow
kr -19.16Mkr -4.77Mkr -1.00K
Investing Cash Flow
kr -2.35Mkr -5.36Mkr 0.00
Financing Cash Flow
kr -4.37Mkr 51.34Mkr 10.00M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
kr 187.89Mkr 51.22Mkr 10.00M
Income Tax Paid Supplemental Data
---
Interest Paid Supplemental Data
---
Issuance Of Capital Stock
-kr 51.34Mkr 10.50M
Issuance Of Debt
---
Repayment Of Debt
---
Free Cash Flow
kr -21.50Mkr -10.12Mkr -1.00K
Domestic Sales
---
Foreign Sales
---
Currency in SEK

OncoZenge AB Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis